Search

for
Search:

Did you mean Eyelash Growth?

GlossaryEyelash Growth

natural process where eyelashes develop and lengthen over time

Eyelash growth refers to the natural process by which eyelashes develop and lengthen over time. This process occurs in three phases: anagen (active growth), catagen (transitional), and telogen (resting). Factors such as genetics, age, and health can influence the rate and quality of eyelash growth. Treatments like serums containing prostaglandin analogs can enhance this growth by prolonging the anagen phase.

Related Terms

Sort by

Research

30 / 971 results

research Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”

1 citations , February 2025 in “Journal of the American Academy of Dermatology”

Most men prefer keeping their eyebrows over scalp hair.

research Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata

November 2025 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Among Scalp Non-Responder Patients with Eyebrow/Eyelash Regrowth in the First Year, Continued Treatment with Baricitinib Resulted in Meaningful Scalp Responses for Patients with Severe Alopecia Areata

research 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata

September 2024 in “Journal of the American Academy of Dermatology”

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Characterization of Scalp, Eyelash, and Eyebrow Hair Regrowth in Patients with Severe Alopecia Areata Randomized to Placebo in BRAVE AA1 and BRAVE AA2 Trials

research Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials

June 2024 in “JEADV Clinical Practice”

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

research 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study

1 citations , September 2023 in “Journal of the American Academy of Dermatology”

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

research 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study

1 citations , September 2023 in “Journal of the American Academy of Dermatology”

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

research Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study

July 2023 in “SKIN The Journal of Cutaneous Medicine”

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

research 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata

September 2023 in “Journal of the American Academy of Dermatology”

Concurrent Improvement in Scalp Hair and Eyebrow or Eyelash Regrowth in Patients With Severe Alopecia Areata Treated With Baricitinib

research 42146 Concurrent improvement in scalp hair and eyebrow or eyelash regrowth in patients with severe alopecia areata treated with baricitinib

September 2023 in “Journal of The American Academy of Dermatology”

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

research Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study

November 2023 in “SKIN The Journal of Cutaneous Medicine”

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Continued Treatment With Baricitinib Results in Meaningful Scalp Responses Among Scalp Non-Responder Patients With Eyebrow/Eyelash Regrowth in the First Year

research Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year

November 2024 in “Journal of the European Academy of Dermatology and Venereology”

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

research Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata

1 citations , January 2025 in “CPT Pharmacometrics & Systems Pharmacology”

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

research 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss

1 citations , September 2022 in “Journal of The American Academy of Dermatology”

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

research Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life

May 2015 in “Cancer research”

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Time to Scalp Hair, Eyebrow, and Eyelash Improvement in Patients with Alopecia Areata Treated with Baricitinib in the Phase 2 Portion of the Phase 2/3 BRAVE-AA1 Study

research 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study

1 citations , August 2021 in “Journal of The American Academy of Dermatology”

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Clinical Benefits of Baricitinib Therapy for Severe Alopecia Areata

research Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

November 2023 in “Dermatology and Therapy”

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials

research 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials

September 2024 in “Journal of the American Academy of Dermatology”

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

research Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

185 citations , June 2014 in “Journal of Investigative Dermatology”

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

research Efficacy of tofacitinib in treatment of alopecia universalis in two patients

51 citations , June 2016 in “Journal of the European Academy of Dermatology and Venereology”

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

research Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis

49 citations , March 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

research Treatment of severe alopecia areata with baricitinib

25 citations , October 2019 in “JAAD Case Reports”

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

research Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study

15 citations , January 2025 in “Journal of the European Academy of Dermatology and Venereology”

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

research Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata

11 citations , November 2018 in “Journal of the American Academy of Dermatology”

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

research Topical tofacitinib for the treatment of alopecia areata affecting facial hair

7 citations , April 2021 in “British Journal of Dermatology”

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

research Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study

6 citations , February 2023 in “Journal of the American Academy of Dermatology”

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Efficacy and Safety of Baricitinib in Adult Patients With Severe Alopecia Areata With or Without an Atopic Background From Two Randomized, Placebo-Controlled, Phase 3 Trials

research 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials

3 citations , September 2022 in “Journal of the American Academy of Dermatology”

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

research Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata

1 citations , August 2023 in “JAMA Dermatology”

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

research Regrowth of Upper Eyelid Eyelashes After Making a Surgical Incision on the Upper Eyelid in a Case of Severe Alopecia Areata

1 citations , March 2013 in “Ophthalmic plastic and reconstructive surgery”

Eyelash regrowth occurred after eyelid surgery in a man with severe hair loss.

research Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study

April 2026 in “Clinical and Translational Science”

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

research Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata

February 2026 in “The Journal of Dermatology”

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.